Approval of Audited Financial Results for the Half-year and year ended 31st March 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shanmuga Hospital Ltd reported flat revenue for FY 2025-26 at Rs. 4,806.32 Lakhs (vs Rs. 4,808.67 Lakhs in FY 2024-25), with revenue from operations declining slightly to Rs. 4,743.61 Lakhs. Profit After Tax remained stable at Rs. 421.06 Lakhs, essentially unchanged from Rs. 420.67 Lakhs the prior year. EPS declined to Rs. 3.09 from Rs. 4.03 due to increased share capital from the IPO. The company generated positive operating cash flow of Rs. 1,231.42 Lakhs (vs negative Rs. 156.94 Lakhs), but cash reserves dropped significantly from Rs. 1,258.93 Lakhs to Rs. 192.52 Lakhs due to Rs. 2,046.76 Lakhs capital expenditure on PPE expansion. The Board also decided to voluntarily adopt quarterly reporting for enhanced transparency. Auditors issued an unmodified (clean) opinion.
The company maintained profitability with positive operating cash flows, but flat revenue and significant cash depletion due to expansion capex are concerns. The voluntary adoption of quarterly reporting signals good governance but investors should monitor the cash burn rate and revenue growth trajectory.